endogenous glp 1 production Proposed mechanism of GLP-1 RA impact on sodium and water homeostasis Schematic representation of production of

Sitagliptin in Combination with Metformin Immediate-Release and Glimepiride In a 24-week placebo-controlled study of sitagliptin 100 mg as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin immediate-release and glimepiride (sitagliptin, N=116

Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL

LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose

Hydration & Gut Health Support: Staying hydrated is always important, but especially on GLP-1

doi: 10.1111/1541-4337.12351